GGrantIndex
Sort

261,768 grants matching gene therapy

BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy

$5,780,735
Luis J. Montaner · Wistar Institute · UM1 · FY2023 · AI

Mayo Comprehensive Cancer Center Grant

$5,758,523
Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2010 · CA

Mayo Comprehensive Cancer Center Grant

$5,755,389
Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2015 · CA

Mayo Comprehensive Cancer Center Grant

$5,755,389
Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2016 · CA

Mayo Comprehensive Cancer Center Grant

$5,755,389
Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2018 · CA

GENERAL CLINICAL RESEARCH CENTER

$5,750,006
University Of Michigan At Ann Arbor · M01 · FY2000 · RR

Dominantly Inherited Alzheimer Network

$5,747,863
Randall J Bateman · Washington University · U19 · FY2020 · AG

Regional Oncology Research Center

$5,742,251
Johns Hopkins University · P30 · FY2001 · CA

HARC: HIV accessory and regulatory complexes

$5,740,105
Nevan J Krogan · University Of California, San Francisco · U54 · FY2022 · AI

BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy

$5,736,593
Luis J. Montaner · Wistar Institute · UM1 · FY2024 · AI

REGIONAL PRIMATE RESEARCH CENTER

$5,731,111
Tulane University Of Louisiana · P51 · FY2000 · RR

HARC: HIV accessory and regulatory complexes

$5,719,529
Nevan J Krogan · University Of California, San Francisco · U54 · FY2024 · AI

Neurobiological Predictors of Huntington's Disease

$5,717,035
Jane S Paulsen · University Of Iowa · R01 · FY2012 · NS

BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication

$5,715,517
Douglas F Nixon · George Washington University · UM1 · FY2016 · AI

Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS)

$5,712,981
Bjorn E Oskarsson · Mayo Clinic Jacksonville · U01 · FY2025 · NS

Discovery of new antiviral methylase, protease, and helicase inhibitors of corona-, flavi-, and alphaviruses

$5,701,101
Thomas Tuschl · Hackensack University Medical Center · U19 · FY2022 · AI

REACH: Research Enterprise to Advance a Cure for HIV

$5,683,679
R. Brad Jones · Weill Medical Coll Of Cornell Univ · UM1 · FY2021 · AI

BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication

$5,680,664
Douglas F Nixon · Weill Medical Coll Of Cornell Univ · UM1 · FY2020 · AI

B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection

$5,678,616
Eric Hunter · Emory University · UM1 · FY2025 · AI

B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection

$5,678,510
Eric Hunter · Emory University · UM1 · FY2024 · AI

ADULT LEUKEMIA RESEARCH CENTER

$5,676,717
Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA

REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD

$5,665,215
E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2024 · AG

Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH)

$5,658,950
Daniel Woo · University Of Cincinnati · U01 · FY2013 · NS

An ultra-long-acting oral treatment for opioid use disorder

$5,658,273
Patrick Boen · Lyndra Therapeutics, Inc. · UG3 · FY2019 · DA

URCC NCORP Research Base

$5,649,423
Karen M Mustian · University Of Rochester · UG1 · FY2025 · CA